Molecular Templates, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2017

Reconciliation of Numerator and Denominator

A reconciliation of the numerator and denominator used in the calculation is as follows (in thousands, except share and per share amounts):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
Numerator:
Net loss attributable to common shareholders	$	(11,105	)	$	(3,585	)	$	(17,183	)	$	(9,643	)
Denominator:
Weighted average common shares outstanding - basic and diluted		17,925,585			301,494			6,241,947			301,275
Net loss per share:
Basic and diluted	$	(0.62	)	$	(11.89	)	$	(2.75	)	$	(32.01	)

Warrants, Options and Purchase Rights Excluded from Computation of Diluted Net Loss Per Share

The following outstanding warrants and options were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an antidilutive effect (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2017		2016		2017		2016
Shares issuable upon exercise of warrants		3,274		49		3,274		49
Shares issuable upon exercise of stock options		1,870		856		1,870		856